Brown-Forman (BFB) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Jul, 2026Executive summary
Fiscal 2025 net sales decreased 5% year-over-year to $4.0B, but organic net sales increased 1% after adjusting for divestitures and other items, reflecting resilience amid softening demand and macroeconomic challenges.
Operating income declined 22% to $1.1B, but organic operating income rose 3%; diluted EPS fell 14% to $1.84, impacted by divestitures and one-time items.
Strategic restructuring included a 12% workforce reduction and closure of the Louisville cooperage, incurring $63M in charges but expected to yield $70–$80M in annualized savings.
$420M returned to shareholders via dividends, $350M received from Duckhorn stake sale, and $300M in maturing notes repaid.
Strategic focus included portfolio growth, brand innovation, premiumization, and route-to-consumer improvements in key markets.
Financial highlights
Net sales: $3,975M, down 5% year-over-year; organic net sales up 1%.
Gross profit declined 7% (down 2% organically); gross margin contracted 150 bps to 58.9% due to higher input costs and FX headwinds.
Operating income: $1,107M, down 22% year-over-year; organic operating income up 3%.
Diluted EPS: $1.84, down 14% year-over-year.
Operating expenses declined 10% (organic -6%).
Outlook and guidance
Fiscal 2026 expected to remain volatile with low visibility due to macroeconomic and geopolitical uncertainties, including tariffs.
Organic net sales and operating income both expected to decline in the low-single digit range.
Capital expenditures projected at $125–$135M; effective tax rate expected at 21–23%.
Used barrel sales expected to drop to less than half of FY25 levels, creating a significant headwind.
Latest events from Brown-Forman
- Net sales fell 2% and EPS dropped 8% as emerging markets offset developed market declines.BFB
Q3 20269 Jul 2026 - Bold new strategy and campaign target global growth, innovation, and premiumization.BFB
Investor Day 20259 Jul 2026 - Organic growth continues despite reported declines and market volatility.BFB
Q3 20258 Jul 2026 - Board recommends voting for all proposals; compensation is performance-based and family retains control.BFB
Proxy filing18 Jun 2026 - Net sales fell 1%, but gross margin and cash flow improved; 2027 outlook flat with cost headwinds.BFB
Q4 20265 Jun 2026 - Emerging markets and premium brand expansion drive growth amid U.S. demand softness.BFB
UBS Global Consumer and Retail Conference11 Mar 2026 - Operating income rose 25% and gross margin expanded, despite a 1% sales decline.BFB
Q4 20241 Feb 2026 - Sales and profit declined, but organic growth guidance and dividend increases were reaffirmed.BFB
Q1 202522 Jan 2026 - Cyclical market shifts, global expansion, and efficiency drive a decade-long growth ambition.BFB
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026